| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/27/2011 | EP2039367B1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 04/27/2011 | EP1841316B1 CCN3 protein for use in the treatment and diagnosis of renal diseases |
| 04/27/2011 | EP1589998B1 IL-27 and IL-2 for use in the treatment of cancer |
| 04/27/2011 | EP1585540B1 Medicament and use thereof for tumor therapy |
| 04/27/2011 | EP1578325B1 Stable topical drug delivery compositions |
| 04/27/2011 | EP1419175B1 Replikin peptides and uses thereof |
| 04/27/2011 | EP1317470B1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate tumor therapy |
| 04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
| 04/27/2011 | EP1197218B1 Algae protein polysaccharide extraction and use thereof |
| 04/27/2011 | EP1118660B1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/27/2011 | EP0972031B1 Procollagen assembly |
| 04/27/2011 | CN1845995B Chimeric antigens for breaking host tolerance to foreign antigens |
| 04/27/2011 | CN102037132A Methods for enhanced production of bone morphogenetic proteins |
| 04/27/2011 | CN102037008A Protease stabilized, acylated insulin analogues |
| 04/27/2011 | CN102037007A Selective exosite inhibition of PAPP-A activity against IGFBP-4 |
| 04/27/2011 | CN102037006A Anti-bacterial compositions |
| 04/27/2011 | CN102036740A Filtration method |
| 04/27/2011 | CN102036690A Novel soluble CD83 polypeptides, formulations and methods of use |
| 04/27/2011 | CN102036680A Methods of using corticotropin-releasing factor for the treatment of cancer |
| 04/27/2011 | CN102036679A Treating dyspnea associated with acute heart failure with relaxin |
| 04/27/2011 | CN102036678A Use of defensins against meningitis |
| 04/27/2011 | CN102036677A Heat shock protein GP96 vaccination and methods of using same |
| 04/27/2011 | CN102036676A Novel dual targeting antitumoural conjugates |
| 04/27/2011 | CN102036665A Novel uses of sodium 4-phenylbutyrate (4 PBA) and the pharmaceutically acceptable salts thereof |
| 04/27/2011 | CN102036663A Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| 04/27/2011 | CN102030829A Anti-melanoma cytotoxic lymphocyte (CTL) multi-epitope peptide and application thereof |
| 04/27/2011 | CN102030828A CTLA4-Ig fusion protein mutants with high affinity |
| 04/27/2011 | CN102030822A New human cell factor VSTM1-v2 and application thereof |
| 04/27/2011 | CN102030821A Human placental anti-aging active protein as well as separation method and application thereof |
| 04/27/2011 | CN102030820A Polypeptide used for preventing and treating diabetes and lipid metabolic disturbance |
| 04/27/2011 | CN102030819A Broad spectrum polypeptin and application thereof |
| 04/27/2011 | CN102030818A Peptide inhibiting angiontensin converting enzyme |
| 04/27/2011 | CN102030817A Peptide inhibiting angiontensin converting enzyme |
| 04/27/2011 | CN102030811A Phytolaccagenin derivative and preparation method and application thereof |
| 04/27/2011 | CN102028939A Medicine with hirudin-containing active ingredient |
| 04/27/2011 | CN102028938A Medicament having effects of activating blood and dissolving stasis |
| 04/27/2011 | CN102028937A SOD (Super Oxide Dlsmutase) medicament composition for resisting ageing, reducing blood pressure and blood fat and preparation method thereof |
| 04/27/2011 | CN102028936A Method for preparing oral protein medicament |
| 04/27/2011 | CN102028935A Method for forecasting, preventing and treating septicemia and septic shock and kit |
| 04/27/2011 | CN102028934A Taxol complex preparation drug |
| 04/27/2011 | CN102028933A Medicinal composition containing lipid material nocathiacin antibiotic |
| 04/27/2011 | CN102028932A Application of whey protein peptide in preparation of drugs and health food for enhancing immunity |
| 04/27/2011 | CN102028931A Application of whey protein peptide in preparation of medicines, health foods or foods for improving learning memory |
| 04/27/2011 | CN102028672A Microporous spongy film preparation and preparation method thereof |
| 04/27/2011 | CN102028661A Pegylated recombinant human granulocyte colony stimulating factor freeze-dried powder/injection and preparation method thereof |
| 04/27/2011 | CN101514231B Fusion protein for resisting formation of thrombus targetedly and preparation method and application thereof |
| 04/27/2011 | CN101361804B Enteral nutrition emulsion for tumor patient |
| 04/27/2011 | CN101274096B Stable Batroxobin medicament composition |
| 04/27/2011 | CN101264106B Preparation of lamb stomach extract and its preparation |
| 04/27/2011 | CN101260157B Fusion polypeptide and application thereof in preparing antineoplastic, antiviral and intracellular bacterial parasite infection curing medicament |
| 04/27/2011 | CN101234191B Use of human recombination hepatic stimulator substance for reinforcing anti-apoptosis of liver cancer cell and application thereof |
| 04/27/2011 | CN101172091B Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same |
| 04/27/2011 | CN101143207B Application of natural type, breaking type or No. 5 domain delation variant type beta 2 glycoprotein I in preparing medicine for inhibiting blood vessel newborn |
| 04/27/2011 | CN101130057B Long-acting implantation agent of pentapeptide for thymus gland and method of producing the same |
| 04/26/2011 | US7932375 Kits for detecting rank nucleic acids |
| 04/26/2011 | US7932373 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 04/26/2011 | US7932365 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 04/26/2011 | US7932364 Extended half life; reduced clearance and immunogenicity; industrial scale production; cells, expression cassettes |
| 04/26/2011 | US7932363 Antibody that binds human eosinophil-derived basic protein |
| 04/26/2011 | US7932358 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 04/26/2011 | US7932355 Virally-safe factor VIII with a low content of higher multimers |
| 04/26/2011 | US7932354 Process for the production of collagen material |
| 04/26/2011 | US7932353 Chimeric polypeptide comprising collagen sequences for use as constituents of medicines and cosmetics |
| 04/26/2011 | US7932352 Semaphorin genes (I) |
| 04/26/2011 | US7932351 Soluble kinase receptor for use in identifying modulators to treat and prevent cell proliferative, respiratory, kidney and liver disorders |
| 04/26/2011 | US7932350 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 04/26/2011 | US7932231 Compositions and methods for stimulating gastrointestinal motility |
| 04/26/2011 | US7932230 Antifungal paints and coatings |
| 04/26/2011 | US7932229 Peptides for treatment of tumors/cancer |
| 04/26/2011 | US7932228 Method of treating bone or prostate cancer with selective bradykinin B1 receptor antagonists |
| 04/26/2011 | US7932227 Lacritin-syndecan fusion proteins |
| 04/26/2011 | US7932226 NFκB transcriptional activity inhibitory agent and anti-inflammatory agent and a steroid action enhancing agent |
| 04/26/2011 | US7932225 Glue composition for lung volume reduction |
| 04/26/2011 | US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 04/26/2011 | US7932026 EGFR mutations |
| 04/26/2011 | US7931904 Modulation of MUC1 activity |
| 04/26/2011 | US7931901 T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
| 04/26/2011 | US7931898 Methods and compositions for inhibiting binding of IgE to a high affinity receptor |
| 04/26/2011 | US7931897 Therapeutic agent for hematopoietic tumors |
| 04/26/2011 | US7931022 Method and apparatus for dispensing inhalator medicament |
| 04/26/2011 | CA2522577C Hepatitis c inhibitor compounds |
| 04/26/2011 | CA2446619C Permeation enhancers |
| 04/26/2011 | CA2446112C A method for regulating immune function in primates using the foxp3 protein |
| 04/26/2011 | CA2441260C Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability |
| 04/26/2011 | CA2408838C Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 04/26/2011 | CA2400871C Novel malconic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 04/26/2011 | CA2398497C Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 04/26/2011 | CA2386217C Bioengineered collagen fibrils |
| 04/26/2011 | CA2377529C Injectable hyaluronate-sulfated polysaccharide conjugates |
| 04/26/2011 | CA2376064C Factor viia inhibitors |
| 04/26/2011 | CA2351274C Isolated cocoon silk protein from simulium vittatum and nucleic acids encoding such protein |
| 04/26/2011 | CA2337988C Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2011 | CA2337971C Novel anti-diabetic peptides |
| 04/26/2011 | CA2319093C Sea cucumber carotenoid lipid fraction products and methods of use |
| 04/26/2011 | CA2309602C Methods and compositions for enhancing immune response and for the production of in vitro mabs |
| 04/26/2011 | CA2306024C Buccal, polar and non-polar spray or capsule |
| 04/26/2011 | CA2298934C Vectors derived from antibodies for transferring substances into cells |
| 04/26/2011 | CA2264012C Compositions and methods for polynucleotide delivery |
| 04/26/2011 | CA2215394C Il-17 receptor |
| 04/26/2011 | CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins |